Company: MYSEW
Filing Date: 2025-02-10
Form Type: 424B5
Source: 0001213900-25-011767
Chunk: 21

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 424B5
Chunk 21
---
 in
an offering on January 9, 2025 for which we received aggregate net proceeds of approximately $4,532,000.

After giving effect to the
sale of 1,941,747 shares of common stock in this offering at an assumed public offering price of $3.09 per share, the last reported sale
price of our common stock on The Nasdaq Capital Market on February 6, 2025, and after deducting commissions and estimated aggregate offering
expenses payable by us, our as adjusted pro forma net tangible book value as of September 30, 2024 would have been approximately $14.5
million, or approximately $2.36 per share of common stock. This represents an immediate increase in as adjusted pro forma net tangible
book value of $0.27 per share to our existing stockholders and an immediate dilution in pro forma net tangible book value of $(0.73) per
share to investors participating in this offering at the assumed public offering price.

| Assumed public offering price per share                                                                                |     |   |      |     | $ | 3.09 |
| Pro forma net tangible book value per share as of September 30, 2024                                                   |     | $ | 2.09 |     |   |      |
| Increase in pro forma net tangible per share attributable to this offering                                             |     |   | 0.27 |     |   |      |
| As adjusted pro forma net tangible book value per share as of September 30, 2024, after giving effect to this offering |     |   |      |     |   | 2.36 |
| Dilution in pro forma net tangible book value per share to investors participating in this offering                    |     |   |      |     | $ | 0.73 |

The information discussed
above is illustrative only and will adjust based on the actual public offering price and other terms of this offering determined at pricing.

The above discussion and table
is based on 3,009,329 shares of common stock outstanding as of September 30, 2024 and excludes as of that date:

| ● | 140,570                                                                                         
 shares of our common stock issuable upon the exercise of stock options outstanding under        
 our 2021 Omnibus Equity Incentive Plan as of September 30, 2024, at a weighted-average exercise 
 price of $114.65 per share;                                                                     |

| ● | 459,430                                                                                     
 shares of